EDURANT
NDC 59676-278, rilpivirine hydrochloride, tablet, film coated, from Janssen Products, LP.
- Product NDC
- 59676-278
- Status
- Listed
- Labeler
- Janssen Products, LP
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA202022
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/59676-278 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- RILPIVIRINE HYDROCHLORIDE25 mg/1
Pharmacologic classes
Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]; Non-Nucleoside Analog [EXT]; Non-Nucleoside Reverse Transcriptase Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 59676-278-01 | 59676027801 | 30 TABLET, FILM COATED in 1 BOTTLE (59676-278-01) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/03880372-2c68-45c6-a53a-f420c49541d6NADAC price for package 59676027801
GET /v1/drugs/nadac/59676027801
Use it
Look up 59676-278 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/59676-278 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 59676-278. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.